Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

We Like What We're Seeing In Big Pharma
Seeking Alpha
Tuesday, November 5, 2013 - 8:42am
tags:
Bristol-Myers Squibb, AbbVie, Eli Lilly
Gabapentin Gets A Boost In Treating Alcoholism
Forbes
Tuesday, November 5, 2013 - 8:41am
tags:
gabapentin, alcoholism, generics, Pfizer
Drug pricing challenges diabetes king Novo Nordisk
Reuters
Tuesday, November 5, 2013 - 8:38am
tags:
drug pricing, diabetes, Novo Nordisk
Shire's ADHD drug succeeds in trial to treat binge eating
Reuters
Tuesday, November 5, 2013 - 8:37am
tags:
Shire, binge eating, ADHD, Vyvanse
Novartis Said to Mull Animal-Health Sale in Asset Review
Bloomberg
Tuesday, November 5, 2013 - 8:20am
tags:
Novartis, animal health
Will GlaxoSmithKline Get Away in China?
Wall St. Cheat Sheet
Tuesday, November 5, 2013 - 8:12am
tags:
China, GSK
Endo Health buying Paladin Labs for about $1.5B
Yahoo/AP
Tuesday, November 5, 2013 - 8:11am
tags:
Paladin, Endo Health Solutions, M&A
Veracyte, Inc. Announces Closing of Initial Public Offering
Yahoo
Tuesday, November 5, 2013 - 8:09am
tags:
Veracyte, IPOs
Meet the Tiny Biotech Challenging Amgen and General Electric
Motley Fool
Tuesday, November 5, 2013 - 8:08am
tags:
Amgen, Repligen, General Electric
Therapeutic vaccine upstart Hookipa snags $27M round to fund PhI move
Fierce Biotech
Monday, November 4, 2013 - 4:46pm
tags:
Hookipa, vaccines
Ex-Lilly contract sales rep sues, claiming unpaid bonuses
Fierce Pharma
Monday, November 4, 2013 - 4:39pm
tags:
Eli Lilly, contract reps
Sequenom Becomes Second Casualty Of Myriad Ruling
Seeking Alpha
Monday, November 4, 2013 - 4:36pm
tags:
Sequenom, Illumina, Downs Syndrome, Myriad Genetics
The Drive Behind Ariad Pharmaceuticals' (ARIA) Partial Recovery
TheStreet.com
Monday, November 4, 2013 - 4:35pm
tags:
Iclusig, Ariad Pharmaceuticals
Celldex: A View On The Imminent Release Of Data For The Cancer Vaccine Rindopepimut
Seeking Alpha
Monday, November 4, 2013 - 3:16pm
tags:
vaccines, glioblastoma, rindopepimut, Celldex
MannKind takes bigger 3Q loss as costs increase
Yahoo/AP
Monday, November 4, 2013 - 3:15pm
tags:
MannKind, earnings
Johnson & Johnson to pay $2.2 bln to end U.S. probes -source
Reuters
Monday, November 4, 2013 - 11:47am
tags:
kickbacks, JNJ, Natrecor, off-label, Risperdal
Will Seattle Genetics Stay Ahead of ImmunoGen and Celldex?
Motley Fool
Monday, November 4, 2013 - 10:27am
tags:
Seattle Genetics, Immunogen, Celldex
Arena Pharmaceuticals - Belviq OTC?
Seeking Alpha
Monday, November 4, 2013 - 10:10am
tags:
Belviq, OTC, Arena Pharmaceuticals, obesity, Eisai
3 Promising Biotech Stocks with Upcoming Catalysts
Wall St. Cheat Sheet
Monday, November 4, 2013 - 10:08am
tags:
Sarepta Therapeutics, eteplirsen, NeoStem, AMR-001, Celldex, CDX-110
Novartis Faces Criminal Complaint Over Diovan Research In Japan
Pharmalot
Monday, November 4, 2013 - 10:04am
tags:
Novartis, Diovan, R&D, Japan

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.